Vaccination bills are popping up in more than 15 states as lawmakers aim to potentially resurrect or create new religious ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for ...

Introduction While many interventions aim to raise measles vaccination coverage in low-income and middle-income countries ...

The bills would restrict how employers treat vaccination and require a reporting system for "vaccine injuries." ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

DOGE chief Elon Musk has put the Consumer Financial Protection Bureau (CFPB) on notice that it could soon be eliminated.

Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This ...

AIM ImmunoTech (AIM) announced its initiation of a plan to advance Ampligen as a vaccine adjuvant for avian influenza as part of the Company’s ...

The issuer is solely responsible for the content of this announcement.